Johnson & Johnson raises guidance

Statements (10 of 13)

1. ▲ Bullish

   Johnson and Johnson beat earnings expectations

   247wallst.comOct 14, 2026 11:15 UTCHigh importance
2. ▲ Bullish

   Johnson and Johnson raised guidance for future periods

   247wallst.comOct 14, 2026 11:15 UTCHigh importance
3. ▲ Bullish

   Johnson & Johnson beat and raised its earnings per share

   finance.yahoo.comOct 14, 2026 11:15 UTCHigh importance
4. ▼ Bearish

   Johnson & Johnson reported results that caused the pharmaceutical sector to be pressured.

   di.seOct 13, 2026 20:04 UTC
5. ▲ Bullish

   Johnson & Johnson beat adjusted earnings estimates

   nasdaq.comOct 13, 2026 17:10 UTCHigh importance
6. ▲ Bullish

   Johnson & Johnson raised its full-year guidance.

   deraktionaer.deOct 13, 2026 11:19 UTCHigh importance
7. ▲ Bullish

   Johnson & Johnson beats estimates and raises 2026 guidance

   finance.yahoo.comOct 13, 2026 11:00 UTCHigh importance
8. ● Neutral

   Johnson & Johnson raises earnings guidance despite a stumble in the pharma sector.

   barrons.comOct 13, 2026 10:51 UTC
9. ▲ Bullish

   Johnson & Johnson is raising its earnings outlook following a significant increase in quarterly drug sales.

   bloomberg.comOct 13, 2026 10:20 UTCHigh importance
10. ▲ Bullish

    Johnson & Johnson raised its 2026 outlook after second-quarter sales increased 6.6% to $25.3 billion.

    insidermonkey.comOct 7, 2026 21:13 UTCHigh importance

3 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=10ea85b9-1871-4912-8cfd-afc987477c32 Get a free API key ↗